Clinical Trials in Texas

Showing 4881-4900 of 11,487 trials

Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

NCT00028678

RATIONALE: Dalteparin may stop the growth of cancer by stopping blood flow to the tumor and by blocking the enzymes necessary for tumor cell growth. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining dalteparin with radiation therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining dalteparin with radiation therapy in treating patients who have newly diagnosed supratentorial glioblastoma multiforme.

Brain and Central Nervous System Tumors

Eastern Cooperative Oncology Group45 participantsStarted Jul 2002

Tampa, Florida, United States • Urbana, Illinois, United States • Kalamazoo, Michigan, United States +9 more locations

COMPLETEDPhase 343 miles

Treatment of Moderate to Severe Glabellar Lines

NCT04249583

The objective of the study is to evaluate the efficacy and safety of a single dose of QM1114-DP compared to placebo for the treatment of moderate to severe GL.

Glabellar Frown Lines

Galderma R&D300 participantsStarted Feb 2020

Manhattan Beach, California, United States • Vista, California, United States • New Orleans, Louisiana, United States +11 more locations

Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Treatment of Moderate to Severe Glabellar Lines

Find Trials by Condition in Texas

Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines

Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management

Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression

A Long Term Safety Study of BCX7353 in Hereditary Angioedema

Study of MT-5111 in HER2-positive Solid Tumors

A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection

Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based Medications Changes

Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma

Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach

Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer

A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype

Treatment of Moderate to Severe Lateral Canthal Lines